IL157444A0 - Labeled macrophase scavenger receptor antagonists and diagnostic and pharmaceutical compositions containing the same - Google Patents
Labeled macrophase scavenger receptor antagonists and diagnostic and pharmaceutical compositions containing the sameInfo
- Publication number
- IL157444A0 IL157444A0 IL15744402A IL15744402A IL157444A0 IL 157444 A0 IL157444 A0 IL 157444A0 IL 15744402 A IL15744402 A IL 15744402A IL 15744402 A IL15744402 A IL 15744402A IL 157444 A0 IL157444 A0 IL 157444A0
- Authority
- IL
- Israel
- Prior art keywords
- macrophase
- diagnostic
- labeled
- pharmaceutical compositions
- same
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0497—Organic compounds conjugates with a carrier being an organic compounds
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Optics & Photonics (AREA)
- Pharmacology & Pharmacy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pyridine Compounds (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US27095401P | 2001-02-23 | 2001-02-23 | |
| PCT/US2002/005156 WO2002067761A2 (fr) | 2001-02-23 | 2002-02-22 | Antagonistes des recepteurs eboueurs des macrophages marques de maniere detectable pour l'identification d'une atherosclerose et d'une plaque vulnerable par imagerie |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL157444A0 true IL157444A0 (en) | 2004-03-28 |
Family
ID=23033552
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL15744402A IL157444A0 (en) | 2001-02-23 | 2002-02-22 | Labeled macrophase scavenger receptor antagonists and diagnostic and pharmaceutical compositions containing the same |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US6869590B2 (fr) |
| EP (1) | EP1377321A4 (fr) |
| JP (1) | JP2004530654A (fr) |
| CN (1) | CN1622832A (fr) |
| AU (1) | AU2002254000A1 (fr) |
| BR (1) | BR0207521A (fr) |
| CA (1) | CA2438174A1 (fr) |
| CZ (1) | CZ20032564A3 (fr) |
| HU (1) | HUP0400027A3 (fr) |
| IL (1) | IL157444A0 (fr) |
| MX (1) | MXPA03007534A (fr) |
| WO (1) | WO2002067761A2 (fr) |
Families Citing this family (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20040015234A (ko) | 2001-05-02 | 2004-02-18 | 펄듀 리서치 파운데이션 | 대식세포 매개된 질환의 치료와 진단 |
| CA2449828A1 (fr) * | 2001-06-04 | 2003-01-16 | The General Hospital Corporation | Detection et therapie de plaques vulnerables a l'aide de composes photodynamiques |
| AU2002353823A1 (en) * | 2001-10-16 | 2003-04-28 | Epix Medical, Inc. | Detection and treatment of intravascular lesions |
| US8043603B2 (en) | 2002-02-07 | 2011-10-25 | Endocyte, Inc. | Folate targeted enhanced tumor and folate receptor positive tissue optical imaging technology |
| US8043602B2 (en) | 2002-02-07 | 2011-10-25 | Endocyte, Inc. | Folate targeted enhanced tumor and folate receptor positive tissue optical imaging technology |
| US7018614B2 (en) * | 2002-11-05 | 2006-03-28 | Eastern Isotopes, Inc. | Stabilization of radiopharmaceuticals labeled with 18-F |
| WO2004043497A1 (fr) | 2002-11-05 | 2004-05-27 | Ion Beam Applications S.A. | Stabilisation de radiopharmaceutiques marques par l'isotope 18-f |
| GB0228490D0 (en) * | 2002-12-06 | 2003-01-08 | Amersham Plc | Novel imaging compounds |
| US7297154B2 (en) | 2003-02-24 | 2007-11-20 | Maxwell Sensors Inc. | Optical apparatus for detecting and treating vulnerable plaque |
| US7153299B1 (en) | 2003-02-24 | 2006-12-26 | Maxwell Sensors Inc. | Optical apparatus for detecting and treating vulnerable plaque |
| US7803352B2 (en) * | 2003-03-07 | 2010-09-28 | John Steele Fisher | Method for continuous visualization of a blood clot or plaque in body lumen |
| EP1629281B1 (fr) | 2003-05-30 | 2008-10-29 | Purdue Research Foundation | Procede de diagnostic de l'atherosclerose |
| WO2005032471A2 (fr) * | 2003-10-03 | 2005-04-14 | Merck & Co., Inc. | Inhibiteurs de type benzylether et benzylamino de beta-secretase pour le traitement de la maladie d'alzheimer |
| EP1602931A1 (fr) * | 2004-06-03 | 2005-12-07 | Universiteit Leiden | Antagoniste du SR-A |
| WO2006012201A1 (fr) * | 2004-06-25 | 2006-02-02 | The Regents Of The University Of California | Nanoparticules pour l'imagerie de plaque athérosclérotique |
| US7575738B2 (en) | 2004-08-13 | 2009-08-18 | General Electric Company | Heat shock protein as a targeting agent for endothelium-specific in vivo transduction |
| EP1827239B1 (fr) * | 2004-12-23 | 2019-04-17 | Purdue Research Foundation | Procede d'imagerie par tomographie par emission de positrons |
| US20070009434A1 (en) | 2005-07-05 | 2007-01-11 | Low Philip S | Imaging and therapeutic method using monocytes |
| US7874975B2 (en) * | 2005-07-20 | 2011-01-25 | Clear Vascular, Inc. | Methods and compositions for treating luminal inflammatory disease |
| WO2007038346A2 (fr) | 2005-09-23 | 2007-04-05 | Purdue Research Foundation | Procede et dispositif de cytometrie en flux in vivo multiphoton |
| US20070196282A1 (en) * | 2006-02-21 | 2007-08-23 | Siemens Medical Solutions Usa, Inc. | Medical diagnostic ultrasound with temperature-dependent contrast agents |
| US8685752B2 (en) | 2006-11-03 | 2014-04-01 | Purdue Research Foundation | Ex vivo flow cytometry method and device |
| US8586595B2 (en) * | 2007-02-07 | 2013-11-19 | Purdue Research Foundation | Positron emission tomography imaging method |
| WO2008148001A2 (fr) * | 2007-05-25 | 2008-12-04 | Purdue Research Foundation | Methode d'imagerie d'infections localisees |
| AU2008324186B2 (en) * | 2007-11-07 | 2014-02-13 | Ge Healthcare Bv | Stabilization of radiopharmaceuticals |
| US20090287120A1 (en) | 2007-12-18 | 2009-11-19 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Circulatory monitoring systems and methods |
| US8636670B2 (en) | 2008-05-13 | 2014-01-28 | The Invention Science Fund I, Llc | Circulatory monitoring systems and methods |
| US9717896B2 (en) | 2007-12-18 | 2017-08-01 | Gearbox, Llc | Treatment indications informed by a priori implant information |
| CN103965128B (zh) | 2008-01-08 | 2018-04-03 | 兰休斯医疗成像公司 | 作为显像剂的n‑烷氧基酰胺共轭物 |
| US20100178245A1 (en) * | 2009-01-13 | 2010-07-15 | Arnsdorf Morton F | Biocompatible Microbubbles to Deliver Radioactive Compounds to Tumors, Atherosclerotic Plaques, Joints and Other Targeted Sites |
| EP2451776B1 (fr) | 2009-07-08 | 2019-09-18 | Lantheus Medical Imaging, Inc. | Conjugués n-alkoxyamides en tant qu'agents d'imagerie |
| US20150023873A1 (en) | 2011-11-11 | 2015-01-22 | Lantheus Medical Imaging, Inc. | Evaluation of presence of and vulnerability to atrial fibrillation and other indications using matrix metalloproteinase-based imaging |
| WO2016200895A1 (fr) | 2015-06-09 | 2016-12-15 | Cummins Filtration Ip, Inc. | Systèmes et procédés pour utiliser un joint de contact de coalesceur rotatif à faible friction |
| CN111212606B (zh) * | 2017-08-15 | 2024-03-01 | 皇家飞利浦有限公司 | 频率可调谐血管内超声设备 |
| WO2019118592A1 (fr) * | 2017-12-12 | 2019-06-20 | Massachusetts Institute Of Technology | Capteurs d'imagerie à perméabilité cellulaire et leurs utilisations |
Family Cites Families (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4577042A (en) * | 1983-03-17 | 1986-03-18 | California Institute Of Technology | Homogeneous coordination compounds as oxidation catalysts |
| US4678667A (en) | 1985-07-02 | 1987-07-07 | 501 Regents of the University of California | Macrocyclic bifunctional chelating agents |
| US4752141A (en) | 1985-10-25 | 1988-06-21 | Luxtron Corporation | Fiberoptic sensing of temperature and/or other physical parameters |
| AU6621586A (en) | 1985-11-18 | 1987-06-02 | University Of Texas System, The | Polychelating agents for image and spectral enhancement (and spectral shift) |
| MX174467B (es) | 1986-01-23 | 1994-05-17 | Squibb & Sons Inc | 1,4,7-triscarboximetil-1,4,7,10-tetraazaciclodo decano substituido en 1 y compuestos analogos |
| US4885363A (en) | 1987-04-24 | 1989-12-05 | E. R. Squibb & Sons, Inc. | 1-substituted-1,4,7-triscarboxymethyl-1,4,7,10-tetraazacyclododecane and analogs |
| GB8603537D0 (en) | 1986-02-13 | 1986-03-19 | Parker D | Conjugate compound |
| GB8719042D0 (en) | 1987-08-12 | 1987-09-16 | Parker D | Conjugate compounds |
| US4923985A (en) | 1988-05-25 | 1990-05-08 | The United States Of America As Represented By The Department Of Health & Human Services | Process for synthesizing macrocyclic chelates |
| AU630362B2 (en) | 1988-05-25 | 1992-10-29 | United States of America, as represented by the Secretary, U.S. Department of Commerce, The | Macrocyclic chelates & methods of use thereof |
| US5756065A (en) | 1988-06-24 | 1998-05-26 | The Dow Chemical Company | Macrocyclic tetraazacyclododecane conjugates and their use as diagnostic and therapeutic agents |
| LU87403A1 (fr) | 1988-12-06 | 1990-07-10 | Oreal | Procede de teinture de fibres keratiniques avec un hydroxyindole,associe a un derive quinonique |
| WO1990009379A1 (fr) | 1989-02-10 | 1990-08-23 | Celltech Limited | Aza-macrocycles et procedes pour leur preparation |
| US5914095A (en) | 1989-04-07 | 1999-06-22 | Salutar, Inc. | Polychelants containg amide bonds |
| US5364613A (en) | 1989-04-07 | 1994-11-15 | Sieving Paul F | Polychelants containing macrocyclic chelant moieties |
| US4986671A (en) | 1989-04-12 | 1991-01-22 | Luxtron Corporation | Three-parameter optical fiber sensor and system |
| US5087440A (en) | 1989-07-31 | 1992-02-11 | Salutar, Inc. | Heterocyclic derivatives of DTPA used for magnetic resonance imaging |
| AU7587091A (en) | 1990-03-26 | 1991-10-21 | United States of America, as represented by the Secretary, U.S. Department of Commerce, The | A fonctionalized complexand |
| US5275594A (en) | 1990-11-09 | 1994-01-04 | C. R. Bard, Inc. | Angioplasty system having means for identification of atherosclerotic plaque |
| KR930019648A (ko) | 1992-03-27 | 1993-10-18 | 도키 가츠유키 | 테트라아자시클로도덴칸 유도체 및 그의 용도 |
| US5310535A (en) | 1992-04-24 | 1994-05-10 | The Dow Chemical Company | Carboxamide modified polyamine chelators and radioactive complexes thereof for conjugation to antibodies |
| US5744120A (en) | 1993-03-30 | 1998-04-28 | The Dupont Merick Pharmaceutical Company | Ternary radiopharmaceutical complexes |
| US5428156A (en) | 1993-04-02 | 1995-06-27 | Associated Universities, Inc. | Synthesis of macrocyclic polyaminocarboxylates and their use for preparing stable radiometal antibody immunoconjugates for therapy, spect and pet imaging |
| WO1995026206A1 (fr) | 1994-03-28 | 1995-10-05 | The Regents Of The University Of California | Procede d'elaboration de complexes agent de chelation-ligand etiquetes par radionucleide |
| IT1283218B1 (it) | 1996-03-08 | 1998-04-16 | Bracco Spa | Polichelanti, loro complessi con ioni metallici, loro preparazione e loro usi |
| US5879659A (en) | 1996-03-13 | 1999-03-09 | Dupont Pharmaceuticals Company | Ternary radiopharmaceutical complexes |
| US5848367A (en) | 1996-09-13 | 1998-12-08 | Sony Corporation | System and method for sharing a non-volatile memory element as a boot device |
| US6403054B1 (en) | 1997-05-28 | 2002-06-11 | Bristol-Myers Squibb Pharma Company | Ternary ligand complexes useful as radiopharmaceuticals |
| CA2298824A1 (fr) | 1997-08-06 | 1999-02-18 | Smithkline Beecham Corporation | Antagonistes des recepteurs des monocytes macrophages pouvant etre utilises pour traiter les maladies vasculaires |
| AU755564B2 (en) | 1998-06-20 | 2002-12-12 | Washington University | Membrane-permeant peptide complexes for medical imaging, diagnostics, and pharmaceutical therapy |
| CA2338122A1 (fr) * | 1998-07-20 | 2000-01-27 | Smithkline Beecham Corporation | Antagonistes des recepteurs des monocytes macrophages |
| JP2002521437A (ja) | 1998-07-30 | 2002-07-16 | スミスクライン・ビーチャム・コーポレイション | マクロファージ・スカベンジャー受容体アンタゴニスト |
-
2002
- 2002-02-22 AU AU2002254000A patent/AU2002254000A1/en not_active Abandoned
- 2002-02-22 WO PCT/US2002/005156 patent/WO2002067761A2/fr active Application Filing
- 2002-02-22 US US10/080,974 patent/US6869590B2/en not_active Expired - Fee Related
- 2002-02-22 EP EP02723207A patent/EP1377321A4/fr not_active Withdrawn
- 2002-02-22 CZ CZ20032564A patent/CZ20032564A3/cs unknown
- 2002-02-22 CN CNA028087704A patent/CN1622832A/zh active Pending
- 2002-02-22 IL IL15744402A patent/IL157444A0/xx unknown
- 2002-02-22 JP JP2002567138A patent/JP2004530654A/ja active Pending
- 2002-02-22 CA CA002438174A patent/CA2438174A1/fr not_active Abandoned
- 2002-02-22 MX MXPA03007534A patent/MXPA03007534A/es active IP Right Grant
- 2002-02-22 HU HU0400027A patent/HUP0400027A3/hu unknown
- 2002-02-22 BR BR0207521-0A patent/BR0207521A/pt not_active IP Right Cessation
-
2003
- 2003-08-14 US US10/641,688 patent/US6974567B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JP2004530654A (ja) | 2004-10-07 |
| US20020127181A1 (en) | 2002-09-12 |
| EP1377321A4 (fr) | 2006-01-11 |
| HUP0400027A2 (hu) | 2004-04-28 |
| US6974567B2 (en) | 2005-12-13 |
| US6869590B2 (en) | 2005-03-22 |
| CN1622832A (zh) | 2005-06-01 |
| HUP0400027A3 (en) | 2006-01-30 |
| MXPA03007534A (es) | 2003-12-04 |
| WO2002067761A3 (fr) | 2003-02-13 |
| WO2002067761A2 (fr) | 2002-09-06 |
| US20040057900A1 (en) | 2004-03-25 |
| AU2002254000A1 (en) | 2002-09-12 |
| BR0207521A (pt) | 2004-06-01 |
| CZ20032564A3 (cs) | 2004-09-15 |
| CA2438174A1 (fr) | 2002-09-06 |
| EP1377321A2 (fr) | 2004-01-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL157444A0 (en) | Labeled macrophase scavenger receptor antagonists and diagnostic and pharmaceutical compositions containing the same | |
| HUP0302969A3 (en) | Npyy5 antagonists, pharmaceutical compositions containing them and their use | |
| HUP0303081A3 (en) | Thrombin receptor antagonists, pharmaceutical compositions containing them and their use | |
| HUP0400251A3 (en) | 5-ht receptor ligands and uses thereof and pharmaceutical compositions containing them | |
| IL169575A0 (en) | Calcium-sensing receptor antagonist compounds and pharmaceutical compositions containing the same | |
| HUP0500880A2 (en) | Cxcr3 antagonists and pharmaceutical compositions thereof | |
| HUP0500107A3 (en) | 1-alkyl-1-azoniabicyclo[2.2.2.]octane carbamate derivatives, pharmaceutical compositions comprising thereof and their use as muscarinic receptor antagonists | |
| SI1381346T1 (sl) | Farmacevtski sestavki, ki vsebujejo formoterol | |
| HUP0303258A3 (en) | N-substituted nonaryl-heterocyclic nmda/nr2b antagonists and pharmaceutical compositions containing them | |
| HUP0303651A3 (en) | N-(2-arylethyl)benzylamines as antagonists of the 5-ht6 receptor and pharmaceutical compositions containing them | |
| IL161616A0 (en) | Indazolypyrrolotriazine derivatives and pharmaceutical compositions containing the same | |
| HK1072200A1 (en) | Pro-micelle pharmaceutical compositions | |
| IL163366A (en) | Glucocorticoid mimetics, pharmaceutical compositions thereof and uses thereof for the preparation of pharmaceutical compositions | |
| HUP0301654A3 (en) | Novel n-pyrimidinyl-sulfamides, their use as endothelin receptor antagonists and pharmaceutical compositions containing them | |
| HUP0402003A3 (en) | Substituted 1,4-benzodiazepines, pharmaceutical compositions containing them and uses thereof | |
| IL158300A0 (en) | Bisarylimidazol derivatives and pharmaceutical compositions containing the same | |
| HUP0302382A3 (en) | Il-8 receptor antagonists and pharmaceutical compositions containing them | |
| IL156812A0 (en) | Phthalazinone-piperidino derivatives and pharmaceutical compositions containing the same | |
| IL165388A0 (en) | Macrolide compounds and pharmaceutical compositions containing the same | |
| EG24194A (en) | 5ht-a-partial agonist pharmaceutical compositions | |
| HUP0400850A3 (en) | Oral pharmaceutical compositions | |
| HUP0300599A3 (en) | Il-8 receptor antagonists, pharmaceutical compositions containing them and their use | |
| HUP0400179A3 (en) | 2,5-diarylpyrazines, 2,5-diarylpyridines and 2,5-diarylpyrimidines, their use and pharmaceutical compositions containing them | |
| GB0108470D0 (en) | Pharmaceutical compositions and their use | |
| HUP0302003A3 (en) | Il-8 receptor antagonists and pharmaceutical compositions containing them |